1,2-dioctanoylglycerol has been researched along with Reperfusion Injury in 2 studies
1,2-dioctanoylglycerol: functions as bioregulator of protein kinase C in human platelets
Reperfusion Injury: Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baxter, GF | 1 |
| Mocanu, MM | 1 |
| Yellon, DM | 1 |
| Reshef, A | 1 |
| Sperling, O | 1 |
| Zoref-Shani, E | 1 |
2 other studies available for 1,2-dioctanoylglycerol and Reperfusion Injury
| Article | Year |
|---|---|
Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivo.
Topics: Animals; Blood Pressure; Diglycerides; Enzyme Activation; Heart Rate; Heat-Shock Proteins; Hemodynam | 1997 |
Activation and inhibition of protein kinase C protect rat neuronal cultures against ischemia-reperfusion insult.
Topics: Alkaloids; Animals; Benzophenanthridines; Cells, Cultured; Diglycerides; Enzyme Activation; Enzyme I | 1997 |